Cornell Found Something in Your Muscles That Changes Everything About Vitamin B12

The Biggest Rapamycin Trial in History Just Launched — 720 People, 6 Years, One Question: Can We Chemically Stop Frailty?

The University of Arizona has launched a randomized, double-blind Phase 3 clinical trial enrolling 720 participants to test whether rapamycin — an immunosuppressant drug with decades of lifespan-extension data in animals — can slow human aging. The trial is funded by $12 million in philanthropic support from alumnus Ken Coit and is projected to take six years. Participants will take rapamycin or a placebo for two years, followed by an additional year of follow-up. The trial focuses on two primary endpoints: whether rapamycin can prevent older adults from transitioning from pre-frail to frail, and whether it can reduce blood levels of IL-6, an inflammatory marker associated with frailty and age-related disease.

The frailty endpoint is a deliberate strategic choice. Rather than chasing individual diseases, the trial bets that frailty captures the underlying structural collapse that makes those diseases more likely. Community commentary from the longevity research space flagged a real tension: an earlier exploratory trial of once-weekly 6 mg sirolimus not only failed to enhance functional improvements from a home exercise program in older adults, but in sensitivity analyses may have modestly reduced those improvements — and increased the burden of minor adverse events, with a possible contribution to one serious infection.

The Arizona trial is using 8 mg per week. Observers are watching closely to see how that dose threads the needle between efficacy and immunosuppression risk. If the data comes back clean, this is the trial that hands regulators a case for the first drug explicitly approved to target aging itself.

Gobble's Take: Rapamycin has been the darling of longevity science for years — this trial will either crown it or quietly retire it, and either answer is worth six years of waiting.

Sources: r/longevity · University of Arizona News

Cornell Research Reframes Vitamin B12 as a Key Regulator of Muscle Energy

Martha Field, associate professor in Cornell's Division of Nutritional Sciences, put it plainly: "This is the first study that shows B12 deficiency affects skeletal muscle mitochondrial energy production." The study, published in the Journal of Nutrition, reframes a vitamin most people associate with anemia and nerve health as a central regulator of how muscles produce energy. Anna Thalacker-Mercer, from the University of Alabama at Birmingham, wondered whether B12 supplementation in aged mice would improve muscle mitochondrial function — it did.

The research mapped B12's interactions across lipid metabolism, organelle stress pathways, and epigenetic regulation — territory that previous research largely ignored in favor of tracking the visible consequences of deficiency, like megaloblastic anemia, neuropathy, and cognitive decline. The results suggest B12 plays a central regulatory role across multiple interconnected biological systems. Even modest deficiencies could have widespread effects. Field also noted that B12 deficiency appeared to inhibit growth or maintenance of muscle mass, with low B12 status associated with lower muscle mass and possibly reduced muscle strength.

B12 deficiency is already widespread globally, particularly among older adults — estimates suggest about one in four older adults in developed countries may have suboptimal levels. The study also identifies early warning signals that may detect nutritional strain long before classic deficiency symptoms appear. The current findings are based on cell models and will need to be validated in human studies.

Gobble's Take: If you're optimizing sleep, training, and fasting but haven't checked your B12 levels recently, you may be leaving your mitochondria starving on the most basic input.

Source: r/Health

48, 192 Pounds, Bloodwork a Mess — Then 12 Weeks of Peptides and HIIT Changed Everything

A 48-year-old biohacker posted his 3-month results on r/Biohacking this week: down from 192 to 170 pounds over exactly 12 weeks, with bloodwork he described as "phenomenal." His protocol combined Retatrutide (a GLP-class peptide, dosed from 1 mg up to 3 mg), Tesamorelin for the first two months, GHK-cu daily, SS31 and MOTS-c added in the final two weeks, a 75% reduction in alcohol, and five days a week of HIIT.

The response in the comments was immediate. One user at roughly the same starting weight and age — 5'9", approaching 48 — called it "motivation and hope." Another reported a similar arc: 203 to 160 pounds from January to April, now focused on adding back muscle. What the thread captures isn't just one person's results — it's a growing cohort of men in their late 40s running peptide stacks alongside serious lifestyle changes and documenting the outcomes with bloodwork and body composition scans.

None of this is FDA-approved as a longevity protocol. Retatrutide is still in clinical development. The compounds here carry real unknowns, and "phenomenal bloodwork" in a Reddit post is not a peer-reviewed outcome. But the pattern — aggressive lifestyle intervention layered with targeted peptides, tracked obsessively — is exactly what the biohacking edge looks like before the clinical literature catches up.

Gobble's Take: The most interesting longevity data right now isn't coming from journals — it's coming from 48-year-olds with DEXA scans and a spreadsheet.

Source: r/Biohacking

Testosterone Up 2.5x, Wrinkles Gone, 8% Body Fat — One Biohacker's 4-Month Stack Breakdown

He described himself in week one as "decrepit." Four months later, his before-and-after photos showed dramatically improved skin quality, visible muscle definition, and a comment section fixated on one thing: what is "K Low" and where do I get it? The biohacker's protocol included 6.5 mg of Enclomiphene — a selective estrogen receptor modulator used to raise endogenous testosterone — which he reported pushed his total testosterone from 600 to 1,500 and free testosterone from 100 to over 250. He added 2.5 mg of Cialis daily for blood flow (he noted nicotine abuse from a young age as the reason), K Low for skin, CJC + Ipamorelin as growth hormone-releasing peptides, and Epithalon.

By month two, the changes were largely aesthetic — less drawn, skin visibly different — without significant muscle mass yet. By month four, a DEXA scan showed body fat moving from 8% to 9%. He added lean mass with what he described as minimal fat gain, photographed in the morning, hydrated, on creatine. The weight gain itself was the point: he started at 118 pounds and reached 135 over the four months.

The K Low comments were their own thread. "That difference in your skin quality is crazy," one commenter wrote, already waiting on their own supply. The interest tracks with growing attention to compounds targeting skin inflammation and scarring as outward biomarkers of biological age — the face as a readout of what's happening inside.

Gobble's Take: When your skin is aging faster than your chronological age, it's not a cosmetics problem — it's a signal your biology is under stress, and some biohackers are treating it accordingly.

Source: r/Biohacking

In Case You Missed It

Yesterday's top stories:

• A Half-Trillion-Dollar Signal That the Longevity Era Has Officially Begun
• Rapamycin Extends Lifespan in Every Model Organism. Humans Are the Hard Part.
• Why AI-Discovered Genes May Outperform the Best Reprogramming Factors We Know
• Sleep Resets the Biology Every Longevity Protocol Is Trying to Protect
• Lifting Weights After 60 Does Something to Your Brain That Cardio Alone Doesn't